《Biopharmaceutics and Pharmacokinetics》课程教学大纲(三号黑体)
一、课程基本信息
英文名称 | Biopharmaceutics andPharmacokinetics | 课程代码 | PHAR1091 |
课程性质 | 专业必修课程 | 授课对象 | 医18药学全英文 |
学 分 | 2.5 | 学 时 | 36 |
主讲教师 | 崔京浩 阮建清 | 修订日期 | 2021.6.25 |
指定教材 | Applied Biopharmaceutics & Pharmacokinetics(7th version) |
二、课程目标
(一)总体目标:
Biopharmaceutics and Pharmacokinetics is a major required courses for pharmaceutical students. This course aims to provide professional information to students and benefit for an overall understanding of pharmaceutical science,familiar with the professional discipline knowledge, to grasp the concept of biopharmaceutics and pharmacokinetics, improve the capability to solve professional problems in drug development and pharmaceutical practices.To develop a sense of discipline identity of biopharmaceutics and pharmacokinetics, to clarify the direction and good learning objectives of future professional learning, and provide guidance for personal professional career development.
(二)课程目标:
Biopharmaceutics and Pharmacokinetics is very important in pharmaceutical area,which is a discipline that investigates the fate of drug in the body dynamically. This course describes factors affecting the absorption, distribution, and metabolism, and excretion of drugs. The students will be able to demonstrate an understanding of the differential and integrated equations associated with pharmacokinetic models and assess factors which affect the absorption, distribution, metabolism and excretion of drugs. At the same time, they will be able to describe the techniques used to determine drug concentrations in biological and formulation matrices and calculate appropriate dosing regimens using appropriate criteria.
课程目标1:(chapter 1,2,4,5,6,7,8,9,10)
1.1 Master the definition of pharmacokinetics, research contents and basic pharmacokinetic parameters, grasp the calculation methods of pharmacokinetic parameters for different administration routes of one-compartment model. Understand the blood drug concentration-time curve and estimation of pharmacokinetic parameters of multi-compartment model, familiar with to identify compartment model. Master the basic concepts related to multi-dose administration, drug accumulation and blood concentration fluctuation.
1.2 Master the characteristics of nonlinear pharmacokinetics and Michaelis–Menten kinetics equation, approach the basic concept of statistical moment and the estimation of pharmacokinetic parameters.
课程目标2:(chapter 11,12,14,15,16)
2.1 Understand the significance of biopharmaceutics and pharmacokinetics to new drug research and development and clinical application.
2.2 Master the structure and properties of biofilms, drug transport mechanism, drug absorption pathways in different parts, and factors affecting drug absorption including physiology, drugs, dosage forms and preparations.
2.3 Master the basic concepts of drug distribution, excretion and metabolism;skilled with the factors that affect drug distribution, the types of drug metabolic reactions and the factors that affect drug metabolism.To master the characteristics and influencing factors of renal excretion and other excretory pathways of drugs.
2.4 Understand the application of pharmacokinetics in clinical pharmacy and new drug research and development, master the design of drug administration regimen, the detection of therapeutic drugs and the individualized design of drug administration regimen. Familiar with the research contents of new drugspharmacokinetics, the basic requirements of bioavailability, research methods and evaluation methods of bioequivalence.
(三)课程目标与毕业要求、课程内容的对应关系
表1:课程目标与课程内容、毕业要求的对应关系表
课程目标 | 课程子目标 | 对应课程内容 | 对应毕业要求 |
课程目标1 | 1.1 Master the definition of pharmacokinetics,research contents and basic pharmacokinetic parameters, grasp the calculation methods of pharmacokinetic parameters for different administration routes of one-compartment model. Understand the blood drug concentration-time curve and estimation of pharmacokinetic parameters of multi-compartment model, familiar with to identify compartment model. Master the basic concepts related to multi-dose administration, drug accumulation and blood concentration fluctuation. | 1 Introduction to biopharmaceutics and pharmacokinetics. 2 Mathematical fundamentals in pharmacokinetics. 4 One compartment open model: Intravenous bolus administration. 5 Multi-compartment models: Intravenous bolus administration 6 Intravenous infusion 8. Pharmacokinetics of oral absorption 9. Multiple-dosage regimens | 具备药动学基础理论、基本知识、基本技能。 |
1.2Master the characteristics of nonlinear pharmacokinetics and Michaelis–Menten kinetics equation, approach the basic concept of statistical moment and the estimation of pharmacokinetic parameters.。 | 10. Nonlinear pharmacokinetics | 具备药动学基础理论、基本知识、基本技能。 | |
1.3 Understand the application of pharmacokinetics in clinical pharmacy and new drug research and development, master the design of drug administration regimen, the detection of therapeutic drugs and the individualized design of drug administration regimen. Familiar with the research contents of new drugs pharmacokinetics, the basic requirements of bioavailability, research methods and evaluation methods of bioequivalence. | 15. Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance 16. Drug Product Performance, In Vivo: Bioavailability and Bioequivalence | 具备从事药物研究方面工作的知识和能力。 具备从事药物动力学与生物药剂学方面工作的知识和能力。 | |
课程目标2 | 2.1 Understand the significance of biopharmaceutics and pharmacokinetics to new drug research and development and clinical application. | 7. Drug elimination, clearance, and renal clearance 11. Physiologic drug distribution and protein binding 12. Drug elimination and hepatic clearance | 具备药学基础理论、基本知识、基本技能。 |
2.2 Master the structure and properties of biofilms, drug transport mechanism, drug absorption pathways in different parts, and factors affecting drug absorption including physiology, drugs, dosage forms and preparations. | 14. Physiologic Factors Related to Drug Absorption | 具备从事药品体内评价方面工作的知识和能力。 | |
2.3 Master the basic concepts of drug distribution, excretion and metabolism;skilled with the factors that affect drug distribution, the types of drug metabolic reactions and the factors that affect drug metabolism.To master the characteristics and influencing factors of renal excretion and other excretory pathways of drugs. | 11. Physiologic Drug Distribution and Protein Binding | 具备从事临床合理用药方面工作的知识和能力。 |
三、教学内容
第一章 Introduction to Biopharmaceutics and Pharmacokinetics
1.教学目标
(1) Understanding the definition of biopharmaceutics and pharmcokinetics, and relationship with drug product performance.
(2) Describe the role of biopharmaceutics and pharmcokinetics in a new drug development and clinical application.
2.教学重难点
(1) The definition of biopharmaceutics and pharmacokinetics.
(2) The application of biopharmaceutics and pharmacokinetics in new drug development and clinical drug application.
3.教学内容
Drug Product Performance, Biopharmaceutics, Pharmacokinetics, Pharmacodynamics, Clinical Pharmacokinetics, Measurement of Drug Concentrations, Basic Pharmacokinetics and Pharmacokinetic Models.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom will be encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第二章 Mathematical Fundamentals in Pharmacokinetics
1.教学目标
(1) Learn to algebraically solve mathematicalexpressions related topharmacokinetics.
(2) Express the calculated andtheoretical pharmacokineticvalues in proper units.
(3) Define various modelsrepresenting rates and orderof reactions and calculatepharmacokinetic parameters(eg, zero- and first-order) fromexperimental data based onthese models.
2.教学重难点
(1) Mathematicalexpressions related topharmacokinetics
(2) Rates and orderof reactions and calculatepharmacokinetic parameters(eg, zero- and first-order) fromexperimental data
3.教学内容
Calculus, Graphs, Mathematical Expressions and Units, Units for Expressing Blood Concentrations, Measurement and Use of Significant Figures, Rates and Orders of Processes.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第三章 One-Compartment Open Model: Intravenous Bolus Administration
1.教学目标
(1) Describe a one-compartmentmodel, IV bolus injection.
(2) Provide the pharmacokineticterms that describe a onecompartment model, IV bolusinjection, and the underlyingassumptions.
(3) Explain how drugs follow onecompartment kinetics usingdrug examples that follow onecompartment kinetics.
(4) Calculate pharmacokineticparameters from drugconcentration–time data using aone-compartment model.
(5) Calculate the IV bolus doseof a drug using the onecompartment model equation.
2.教学重难点
(1) The definition of pharmacokinetic compartment model,the significance of one compartment model for intravenous bolus administration.
(2) The calculation of pharmacokinetic parameters.
3.教学内容
Elimination rate constant, apparent volume of distribution, clearance, clinical application, calculation of k from urinary excretion data.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第四章 Multicompartment Models: Intravenous Bolus Administration
1.教学目标
(1) Define the pharmacokineticterms used in a two- and threecompartment model.
(2) Explain using examples whydrugs follow one-compartment,two-compartment, or threecompartment kinetics.
(3) Use equations and graphto simulate plasma drugconcentration at varioustime periods after an IV bolusinjection of a drug that followsthe pharmacokinetics of a twoand three-compartment modeldrug.
(4) Estimate two-compartmentmodel parameters by using themethod of residuals.
2.教学重难点
Whydrugs follow one-compartment,two-compartment, or threecompartment kinetics, estimate two-compartmentmodel parameters by using themethod of residuals.
3.教学内容
Two-Compartment Open Model, Clinical Application, Three-Compartment Open Model, Determination of Compartment Models, Practical Problem
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第五章 Intravenous Infusion
1.教学目标
(1) Describe the concept of steadystate and how it relates tocontinuous dosing.
(2) Determine optimum dosing foran infused drug by calculatingpharmacokinetic parametersfrom clinical data.
(3) Calculate loading doses tobe used with an intravenousinfusion.
(4) Describe the purpose of aloading dose.
2.教学重难点
Pharmacokinetic parameters for one-compartment model drugs after intravenous infusion, loading dose,estimation of drug clearance and VD.
3.教学内容
One-compartment model drugs, infusion method for calculating patient elimination half-life,loading dose plus iv infusion-one-compartment model,estimation of drug clearance and VD from infusion data.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第六章 Drug Elimination, Clearance, and Renal Clearance
1.教学目标
(1) Describe the main routes of drugelimination from the body.
(2) Understand the importanceof the role of clearance as a PKparameter.
(3) Define clearance and itsrelationship to a correspondinghalf-life and a volume ofdistribution, differentiate between clearanceand renal clearance.
2.教学重难点
The definition and significance of drug elimination, clearance, renal clearance, determination of renal clearance, relationship of clearance to elimination half-life and volume of distribution.
3.教学内容
Drug elimination, drug clearance, clearance models, the kidney, renal clearance, determination of renal clearance, relationship of clearance to elimination half-life and volume of distribution.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第七章 Pharmacokinetics of Oral Absorption
1.教学目标
(1) Define oral drug absorptionand describe the absorptionprocess.
(2) Introduce two generalapproaches used for studyingabsorption kinetics and theirsimilarities and differences.
(3) Understand the basic principlesfor physiologically basedabsorption kinetics.
(4) Describe the oral onecompartment model andexplain how this modelsimulates drug absorption fromthe gastrointestinal tract.
(5) Calculate the pharmacokineticparameters of a drugthat follows the oral onecompartment model, the fraction of drugabsorbed in a one-compartmentmodel using the Wagner–Nelsonmethod.
2.教学重难点
Understand the oral drug absorption principles and process, the basic principles for physiologically based absorption kinetics, calculate the pharmacokinetic parameters of a drug that follows the oral one compartment model.
3.教学内容
Basic principles of physiologically based absorption kinetics (bottom-up approach), absorption kinetics (the top-down approach), pharmacokinetics of drug absorption, significance of absorption rate constants, zero-order absorption model, first-order absorption model.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第八章 Multiple-Dosage Regimens
1.教学目标
(1) Define drug accumulation, accumulation index and drug accumulation t1/2.
(2) Explain the principle ofsuperposition and itsassumptions in multiple-doseregimens.
(3) Calculate the steady-state Cmaxand Cmin after multiple IV bolusdosing of drugs, k and VD ofaminoglycosides in multiple-dose regimens.
2.教学重难点
The definition of drug accumulation and evaluate related pharmacokinetic parameters.
3.教学内容
Drug accumulation, repetitive intravenous injections, intermittent intravenous infusion, estimation of k and VD of aminoglycosides in clinical situations, multiple-oral-dose regimen, loading dose, dosage regimen schedules.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第九章 Nonlinear Pharmacokinetics
1.教学目标
(1) Describe the differences betweenlinear pharmacokinetics andnonlinear pharmacokinetics.
(2) Explain how to detect nonlinearkinetics using AUCversusdosesplots.
(3) Learn to apply Michaelis–Menten equation and graphical methods to calculateVmax and KM.
2.教学重难点
The necessity to study Nonlinear Pharmacokinetics, how to determine Nonlinear Pharmacokinetics, the properties of Nonlinear Pharmacokinetics, calculation of related PK parameters.
3.教学内容
Saturable Enzymatic Elimination Processes, Drug Elimination by Capacity-Limited Pharmacokinetics: One-Compartment Model, IV Bolus Injection, drugs distributed as one-compartment model and eliminated by nonlinear pharmacokinetics, chronopharmacokinetics and time-dependent pharmacokinetics, bioavailability of drugs that follow nonlinear pharmacokinetics, nonlinear pharmacokinetics due to drug–protein binding, potential reasons for unsuspected nonlinearity, dose-dependent pharmacokinetics.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第十章 Physiologic Drug Distribution and Protein Binding
1.教学目标
(1) Describe the physiology of drugdistribution in the body.
(2) Explain how drug distribution isaffected by blood flow, protein,and tissue binding.
(3) Describe how drug distributioncan affect the apparent volumeof distribution.
(4) Explain how volume ofdistribution, drug clearance,and half-life can be affected by
protein binding.
2.教学重难点
The physiology of drugdistribution in the body, factors affect drug distribution, the definition and significance of drug protein binding in vivo, the relationship between drug distribution, drug clearance and half-life of elimination.
3.教学内容
Physiologic factors of distribution, apparent volume distribution, protein binding of drugs, effect of protein binding on the apparent volume of distribution, relationship of plasma drug–protein binding to distribution and elimination, determinants of protein binding, kinetics of protein binding.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第十一章 Drug Elimination and Hepatic Clearance
1.教学目标
(1) Describe the pathways for drugelimination in the body.
(2) Describe the role of hepaticblood flow, drug proteinbinding, and intrinsic clearanceon hepatic clearance.
(3) Describe the biotransformationof drugs in the liver and whichenzymatic processes areconsidered “phase I reactions”and “phase II reactions.”
2.教学重难点
Understanding the definition of drug Drug Elimination and Hepatic Clearance, factors affecting Drug Elimination, biotransformation pathway of drug in vivo.
3.教学内容
Route of drug administration and extrahepatic drug metabolism, hepatic clearance, extrahepatic metabolism, enzyme kinetics, anatomy and physiology of the liver, hepatic enzymes involved in the biotransformation of drugs, drug biotransformation reactions, pathways of drug biotransformation, biliary excretion of drugs, role of transporters on hepatic clearance and bioavailability.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第十二章 Physiologic Factors Related to Drug Absorption
1.教学目标
(1) Define passive , active drugabsorption, transcellular andparacellular drug absorption.
(2) Explain how Fisk's law ofdiffusion relates to passive drugabsorption.
(3) Calculate the percent of drugnonionized and ionized fora weak acid or weak-basedrug using the Henderson–Hasselbalch equation, andexplain how this may affect drugabsorption.
(4) Describe the anatomy andphysiology of the GI tract andexplain how stomach emptyingtime and GI transit time canalter the rate and extent of drugabsorption.
(5) Explain the effect of food ongastrointestinal physiology andsystemic drug absorption.
(6) Describe the varioustransporters and how theyinfluence the pharmacokineticsof drug disposition in the GI tract
(7) Explain the pH-partitionhypothesis and howgastrointestinal pH and the pKaof a drug may influence systemicdrug absorption. Describe howdrug absorption may be affectedby a disease that causes changesin intestinal blood flow and/ormotility.
(8 )List the major factors thataffect drug absorption fromoral and non-oral routes of drugadministration.
2.教学重难点
Understanding the mechanisms of drug absorption, the anatomy and physiology drug absorption organs, the physicochemical and physiological factors influencing drug absorption, important equations to describe the absorption.
3.教学内容
Drug absorption and design of a drug product, route of drug administration, nature of cell membranes, passage of drugs across cell membranes, drug interactions in the gastrointestinal tract, oral drug absorption, oral drug absorption during drug product development, methods for studying factors that affect drug absorption, effect of disease states on drug absorption, miscellaneous routes of drug administration.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第十三章 Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
1.教学目标
(1) Describe the biopharmaceuticfactors affecting drug design.
(2) Differentiate between the termssolubility and dissolution, drug absorption andbioavailability,
(3) Describe the various in vitro andin vivo tests commonly used toevaluate drug products.
(4) Define in vitro–in vivo correlation(IVIVC) and explain why aLevel A correlation is the mostimportant correlation for IVIVC
(5) Explain the biopharmaceuticclassification system andhow solubility, dissolution,and permeation apply to BCSclassification.
2.教学重难点
Understanding the biopharmaceuticfactors affecting drug design, the significance and method to estimate in vitro–in vivo correlation(IVIVC),the biopharmaceuticclassification system andhow solubility, dissolution,and permeation apply to BCSclassification.
3.教学内容
Biopharmaceutic factors and rationale for drug product design, rate-limiting steps in drug absorption, physicochemical properties of the drug, formulation factors affecting drug product performance, drug product performance, in vitro: Dissolution and drug release testing, compendial methods of dissolution, dissolution profile comparisons, problems of variable control in dissolution testing, performance of drug products: In vitro–in vivo correlation, drug product stability, considerations in the design of a drug product.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
第十四章 Drug Product Performance, In Vivo: Bioavailability and Bioequivalence
1.教学目标
(1) Define bioavailability,bioequivalence, and drugproduct performance.
(2) Explain why certain drugsand drug products have lowbioavailability.
(3) Explain why first-pass effect aswell as chemical instability of adrug can result in low relativebioavailability.
(4) Describe various methodsfor measuring bioavailabilityand the advantages anddisadvantages of each.
2.教学重难点
Understanding the difference between bioavailability and bioequivalence, and how these parameters influence drugproduct performance and development.
3.教学内容
Drug Product Performance, Purpose of Bioavailability and Bioequivalence Studies, Relative and Absolute Availability, Methods for Assessing Bioavailability and Bioequivalence, In Vivo Measurement of Active Moiety or Moieties in Biological Fluids, In Vitro Studies, Bioequivalence Studies, Design and Evaluation of Bioequivalence Studies, The Biopharmaceutics Classification System (BCS), Special Concerns in Bioavailability and Bioequivalence Studies.
4.教学方法
(1) Teaching method: Relevant concepts and theoretical framework, combined with typical drug examples.
(2) Discussion method: Flipped classroom was encouraged.
5.教学评价
Take quick summary test, discuss with selected learning questions and frequently asked questions.
四、学时分配
表2:各章节的具体内容和学时分配表
章节 | 章节内容 | 学时分配 |
第一章 | Introduction to Biopharmaceutics and Pharmacokinetics | 2 |
第二章 | Mathematical Fundamentals in Pharmacokinetics | 2 |
第三章 | One Compartment Open Model: Intravenous Bolus Administration | 4 |
第四章 | Multi-compartment Models: Intravenous Bolus Administration | 2 |
第五章 | Intravenous Infusion | 2 |
第六章 | Drug Elimination, Clearance and Renal Clearance | 2 |
第七章 | Pharmacokinetics of Oral Absorption | 2 |
第八章 | Multiple-Dosage Regimens | 2 |
第九章 | Nonlinear Pharmacokinetics | 2 |
第十章 | Physiologic Drug Distribution and Protein Binding | 4 |
第十一章 | Drug Elimination and Hepatic Clearance | 2 |
第十二章 | Physiologic Factors Related to Drug Absorption | 4 |
第十三章 | Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance | 2 |
第十四章 | Drug Product Performance, In Vivo: Bioavailabilityand BioequivalenceDrug Elimination and Hepatic Clearance | 4 |
五、教学进度
表3:教学进度表
周次 | 日期 | 章节名称 | 内容提要 | 授课时数 | 作业及要求 | 备注 |
1 | 3月4日 | 1. Introduction to Biopharmaceutics and Pharmacokinetics | 1. Drug product performance Define drug and product performance and 2. Biopharmaceutics, Pharmacokinetics, Pharmacodynamics 3. Clinical pharmacokinetics 4. Practical Focus, Drug exposure and drug response 5. Measurement of drug concentrations 6. Basic pharmacokinetics and pharmacokinetic models | 2 | Carefully complete the assignment submitted as usual performance | |
2 | 3月11日 | 2.Mathematical Fundamentals in Pharmacokinetics | 1. Calculus 2. Graphs 3. Mathematical expressions and units 4. Rates and orders of processes | 2 | Same as above | |
3 | 3月18日 | 3.One Compartment Open Model: Intravenous Bolus Administration(1) | 1. Elimination rate constant 2. Apparent volume of distribution | 2 | Same as above | |
4 | 3月25日 | 3.One Compartment Open Model: Intravenous Bolus Administration(1) | 3. Clearance 4. Calculation of k from urinary excretion data | 2 | Same as above | |
5 | 4月1日 | 4.Multi-compartment Models: Intravenous Bolus Administration | 1. Concept of multi-compartment model and two-compartment open model 2. Clinical application 3. Determination of compartment models | 2 | Same as above | |
6 | 4月8日 | 5.Intravenous Infusion | 1. One compartment model drugs 2. Infusion method for calculating patient elimination half-life 3. Loading dose plus iv infusion: one-compartment model 4. Intravenous infusion of two-compartment model drugs | 2 | Same as above | |
7 | 4月15日 | 6.Drug Elimination, Clearance and Renal Clearance | 1. Drug elimination 2. Drug clearance and clearance models 3. The kidney and renal clearance 4. Determination of renal clearance 5. Relationship of clearance to elimination half-life and volume of distribution | 2 | Same as above | |
8 | 4月22日 | 7.Pharmacokinetics of Oral Absorption | 1. Introduction 2. Basic principles of physiologically based absorption kinetics 3. Pharmacokinetics of drug absorption 4. Significance of absorption rate constants, zero-order & first-order absorption model | 2 | Same as above | |
9 | 4月29日 | 8.Multiple-Dosage Regimens | 1. Drug accumulation 2. Repetitive intravenous injections and intermittent intravenous infusion 3. Multiple-oral-dose regimen and loading dose 4. Dosage regimen schedules | 2 | Same as above | |
10 | 5月6日 | 9.Nonlinear Pharmacokinetics | 1. Introduction 2. Saturable enzymatic elimination processes 3. Drug elimination by capacity-limited pharmacokinetics 4. Drug distributed as one-compartment model and eliminated by nonlinear pharmacokinetics 5. Bioavailability of drugs that follow nonlinear pharmacokinetics 6. Nonlinear pharmacokinetics due to drug-protein binding | 2 | Same as above | |
11 | 5月13日 | 10.Physiologic Drug Distribution and Protein Binding-1 | 1. Physiologic factors of distribution 2. Apparent volume distribution 3. Protein binding of drugs | 2 | Same as above | |
12 | 5月20日 | 10.Physiologic Drug Distribution and Protein Binding-2 | 4. Effect of protein binding on the apparent volume of distribution 5. Determination methods of protein binding 6. Modeling drug distribution | 2 | Same as above | |
13 | 5月27日 | 11.Drug Elimination and hepatic clearance | 1. Genetic polymorphisms 2. Cytochrome P-450 isozymes 3. Phase two enzymes 4. Transporters | 2 | Same as above | |
14 | 6月3日 | 12.Physiologic Factors Related to Drug Absorption(1) | 1. Drug absorption and design of a drug product 2. Nature of cell membranes 3. Passage of drugs across cell membranes | 2 | Same as above | |
15 | 6月10日 | 12.Physiologic Factors Related to Drug Absorption(2) | 4. Drug interactions in the gastrointestinal tract 5. Oral drug absorption 6. Methods for studying factors that affect drug absorption 7. Miscellaneous routes of drug administration | 2 | Same as above | |
15 | 6月17日 | 13.Biopharmaceutic Considerations in Drug Product Design (1) | 1. Biopharmaceutic factors and rationale for drug product design 2. Rate-limiting steps in drug absorption 3. Physicochemical properties of the drug | 2 | Same as above | |
16 | 6月17日 | 13.Biopharmaceutic Considerations in Drug Product Design (2) | 4. Formulation factors affecting drug product performance 5. Drug product performance, in vitro 6. Compendial methods of dissolution 7. Drug product stability | 2 | Same as above | |
6月21日 | 14.Drug Product Performance, In Vivo: Bioavailabilityand BioequivalenceDrug Elimination and Hepatic Clearance | 1. Drug product performance 2. Purpose of bioavailability and bioequivalence studies 3. Relative and absolute availability | 2 | Same as above | ||
17 | 6月24日 | 14.Drug Product Performance, In Vivo: Bioavailabilityand BioequivalenceDrug Elimination and Hepatic Clearance | 4. Methods for assessing bioavailability and bioequivalence 5. In vivo measurement of active moiety or moieties in biological fluids 6. Bioequivalence studies 7. Pharmacokinetic evaluation of the data | 2 | Same as above |
六、教材及参考书目
1. 刘建平主编,生物药剂学与药物动力学,人民卫生出版社,2016年
2. Patrick J. Sinko,Martin’s Physical Pharmacy and Pharmaceutical Sciences,Wolters Kluwer,2011年.
3. 方亮主编,药剂学,人民卫生出版社,2016年
4. Alexander T Florence, Physicochemical Principles of Pharmacy,Pharmaceutical Press,2006年.
七、教学方法
1. Teaching method: Teaching the basic concepts and principles of this course by PPT and video, etc.,promote the students can understand the relevant professional knowledge of pharmaceutical science.
2.Discussing method: The heuristic teaching method will be employed in the class, and flipping classroom will be used at regular intervals to encourage the active studying and learning presentation techniques, too.
八、考核方式及评定方法
(一)课程考核与课程目标的对应关系
表4:课程考核与课程目标的对应关系表
课程目标 | 考核要点 | 考核方式 |
课程目标1 | Pharmacokinetics:definition,research contents,calculate pharmacokinetic parameters,after various administration routes,one-compartment model, multi-compartment model; how to clarity compartment model; basic concepts of multi-dose administration, drug accumulation,drug concentration fluctuation. The characteristics of nonlinear PK and Michaelis–Menten kinetics equation, basic concept of statistical moment and the estimation PK parameters. | 课堂提问,作业,阶段性测验,期中和期末考试。 |
课程目标2 | The role of BA and PK in new drug research & development, and clinical application. The structure and properties of biofilms, drug transport mechanism, drug absorption pathways and factors affecting drug absorption including physiology, drugs, dosage forms and preparations. The concept of drug distribution, excretion and metabolism;the factors that affect drug distribution, the types of drug metabolic reactions and the factors that affect drug metabolism; the characteristics and influencing factors of renal excretion and other excretory pathways of drugs;the detection of therapeutic drugs and the individualized design of drug administration regimen. | 课堂提问,作业,阶段性测验,期中和期末考试。 |
(二)评定方法
1.评定方法
(例:平时成绩:10%,期中考试:30%,期末考试60%,按课程考核实际情况描述)
2.课程目标的考核占比与达成度分析
表5:课程目标的考核占比与达成度分析表
考核占比 课程目标 | 平时 | 期中 | 期末 | 总评达成度 |
20 | 30 | 50 | 课程目标达成度={0.2x平时目标成绩+0.3x期中目标成绩+0.5x期末目标成绩}/目标总分。) | |
课程目标2 | 20 | 30 | 50 |
(三)评分标准
课程 目标 | 评分标准 | ||||
90-100 | 80-89 | 70-79 | 60-69 | <60 | |
优 | 良 | 中 | 合格 | 不合格 | |
A | B | C | D | F | |
课程 目标1 | 完全掌握 | 非常熟悉 | 熟悉 | 一般 | 较差 |
课程 目标2 | 完全掌握 | 非常熟悉 | 熟悉 | 一般 | 较差 |